Differentiation-associated overexpression of the cyclin-dependent kinase inhibitor p21(waf-1) in human cutaneous squamous cell carcinoma

American Journal of Pathology

Volumn 149, Issue 4, 1996, Pages 1139-1146

  Tron, Victor A ^a   Tang, Liren ^b   Yong, Wei P ^b   Trotter, Martin J ^b  

^a VANCOUVER HOSPITAL AND HEALTH SCIENCES CENTRE   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; PROTEIN KINASE INHIBITOR;

ADULT; AGED; ARTICLE; CANCER INHIBITION; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME SYNTHESIS; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CARCINOGENESIS; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA;

AGED; CALCIUM; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; FEMALE; HUMANS; KERATINOCYTES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 0029815820     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Xiong Y, Zhang H, Beach D: D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 1992, 71:505-514
2. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ: The p21 cdk-interacting Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993, 75:805-816
3. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer E, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 1993, 75:817-825
4. Parker SB, Eichele G, Zhang P, Rawls A, Sands AT, Bradley A, Olson EN, Harper JW, Elledge SJ: p53-independent expression of p21cip1 in muscle and other terminally differentiating cells. Science 1995, 267: 1024-1027
5. Missero C, Calautti E, Eckner R, Chin J, Tsai L, Livingston DM, Dotto GP: Involvement of the cell-cycle inhibitor Cip1/Waf1 and the E1A-associated p300 protein in terminal differentiation. Proc Natl Acad Sci USA 1995, 92:5451-5455
6. Jiang H, Lin J, Su Z, Herlyn M, Kerbel RS, Bernard E, Weissman BE, Welch DR, Fisher PB: The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells. Oncogene 1995, 10:1855-1864
7. Jiang H, Lin J, Su Z, Collart FR, Huberman E, Fisher PB: Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 1994, 9:3397-3406
8. Sheikh MS, Li X, Chen J, Shao Z, Ordonez JV, Fontana JA: Mechanisms of regulation of WAF1/CIP1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways. Oncogene 1994, 9:3407-3415
9. Datto MB, Li Y, Panus JF, Howe DJ, Xiong Y, Wang X: Transforming growth factor-β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci USA 1995, 92: 5545-5549
10. Preston DS, Stern RS: Nonmelanoma cancers of the skin. N Engl J Med 1992, 327:1649-1662
11. Wolber R, Dupuis B, Thiyagaratnam P, Owen D: Anal cloacogenic and squamous cell carcinomas: comparative histologic analysis using in situ hybridization for human papilloma virus DNA. Am J Surg Pathol 1990, 14:176-182
12. Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, Halpern AJ, Ponten J: A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 1991, 88: 10124-10128
13. Li G, Ho VC, Berean K, Tron VA: Ultraviolet light induction of squamous cell carcinoma in p53 transgenic mice. Cancer Res 1995, 55:2070-2074
14. Li G, Mitchell DL, Ho VC, Read JC, Tron VA: Decreased DNA repair but normal apoptosis in UV irradiated p53 transgenic mice. Am J Pathol 1996, 148:1113-1123
15. Scheffner M, Wernew BA, Huigregste JM, Levine AJ, Howley PM: The E6 oncoprotein encoded by human papillomavirus type 16 and 18 promotes the degradation of p53. Cell 1990, 63:1129-1136
16. Klein-Parker H, Warshawski L, Tron VA: Melanocytes in human skin express bcl-2 protein. J Cutaneous Pathol 1994, 21:296-301
17. Markey AC, Lane EB, Churchill LJ, MacDonald DM, Leigh IM: Expression of simple epithelial keratins 8 and 18 in epidermal neoplasia. J Invest Dermatol 1991, 97:763-770
18. Cattoretti G, Becker MHG, Key G, Duchrow M, Schlüter C, Galle J, Gerdes J: Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB-1 and MIB-3) detect proliferating cells in microwaved-processed formalin-fixed paraffin sections. J Pathol 1992, 168:357-363
19. Daley JP, Epstein DA, Hawley-Nelson P Growth of human epidermal keratinocytes in keratinocyte serum-free medium. Focus 1990, 12:68-71
20. WAF1/CIP1 in psoriasis and after the application of irritants and tape stripping. J Invest Dermatol 1995, 105:274-279
21. Pontén F, Berne B, Ren Z, Nistér M, Pontén J: Ultraviolet light induces expression of p53 and p21 in human skin: effect of sunscreen and constitutive p21 expression in skin appendages. J Invest Dermatol 1995, 105:402-406
22. Zhang H, Hannon GJ, Beach D: p21-containing cyclin kinases exist in both active and inactive states. Genes & Dev 1994, 8:1750-1758
23. Bito T, Uedo M, Ahmed N, Nagano T, Ichihashi M: Cyclin D and retinoblastoma gene product expression in actinic keratosis and cutaneous squamous cell carcinoma in relation to p53 expression. J Cutaneous Pathol 1995, 22:427-434
24. Coulter LK, Wolber R, Tron VA: Site-specific comparison of p53 immunostaining in squamous cell carcinoma. Hum Pathol 1995, 26:531-533
25. Weinberg WC, Azzoli CG, Kadiwar N, Yuspa SH: p53 gene dosage modifies growth and malignant progression of keratinocytes expressing the v-rasHa oncogene. Cancer Res 1994, 54:5584-5592
26. Siohara M, El Deiry WS, Wada M, Nakamaki T, Takeuchi S, Yang R, Chen D, Vogelstein B, Koeffler HP: Absence of WAF1 mutations in a variety of human malignancies. Blood 1994, 84:3781-3784
27. Li Y, Laurent-Puig P, Salmon RJ, Thomas G, Hamelin R: Polymorphisms and probable lack of mutation in the WAF1-CIP1 gene in colorectal cancer. Oncogene 1995, 10:599-601
28. Vidai MJ, Loganza F, de Oliveira R, Hayward NK, Albino AP: Mutations and defective expression of the WAF1 p21 tumor-suppressor gene in malignant melanomas. Melanoma Res 1995, 5:243-250
29. DiGuiseppe JA, Redston MS, Yeo CJ, Kern MS, Hruban RH: p53-independent expression of the cyclin-dependent kinase inhibitor p21 in pancreatic carcinoma. Am J Pathol 1995, 147:884-888
30. WAF1/CIP1 expression in normal and neoplastic tissue. Cancer Res 1995, 55:2910-2919